CN105854105B - The pre- punching method of anti-coagulants for sampled plasma - Google Patents

The pre- punching method of anti-coagulants for sampled plasma Download PDF

Info

Publication number
CN105854105B
CN105854105B CN201610257181.5A CN201610257181A CN105854105B CN 105854105 B CN105854105 B CN 105854105B CN 201610257181 A CN201610257181 A CN 201610257181A CN 105854105 B CN105854105 B CN 105854105B
Authority
CN
China
Prior art keywords
blood
coagulants
pump
plasma
pipeline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610257181.5A
Other languages
Chinese (zh)
Other versions
CN105854105A (en
Inventor
翟庆斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU JIAYING MEDICAL PRODUCT Co Ltd
Original Assignee
CHENGDU JIAYING MEDICAL PRODUCT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU JIAYING MEDICAL PRODUCT Co Ltd filed Critical CHENGDU JIAYING MEDICAL PRODUCT Co Ltd
Priority to CN201610257181.5A priority Critical patent/CN105854105B/en
Publication of CN105854105A publication Critical patent/CN105854105A/en
Application granted granted Critical
Publication of CN105854105B publication Critical patent/CN105854105B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672Means preventing coagulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood

Abstract

The invention discloses a kind of pre- punching methods of the anti-coagulants for sampled plasma.It is controlled blood pump and anticoagulant pump including the use of control device and is rotated with same rotational speed, anticoagulant pump turnning circle is counted using counting device, the characteristic value of anticoagulant pump pipeline is calculated using the mass change data of the second gravity measure device measurement anti-coagulants and using the second computing device.The present invention is detected by the blood plasma to each plasma donor with ratio of blood, personalized anti-coagulants usage amount is calculated, it realizes the minimum of anti-coagulants and uses purpose, simultaneously by carrying out real-time measurement to consumptive material characteristic value used in sampled plasma process, it eliminates because of the problem of anti-coagulants caused by different consumptive material differences is using increasing, improves the quality of acquisition blood plasma.

Description

The pre- punching method of anti-coagulants for sampled plasma
The application is patent application: for the anti-coagulants control system of sampled plasma and the divisional application of method, former patent The applying date of application are as follows: 2015-04-24;Application No. is 201510198723.1;Title are as follows: the anti-coagulants for sampled plasma Control system and method.
Technical field
The invention belongs to sampled plasma technical field more particularly to a kind of pre- punching methods of anti-coagulants for sampled plasma.
Background technique
During Plasma Pheresis/Apheresis Plasma, in order to guarantee that the blood in consumptive material does not solidify, need according to a certain percentage by whole blood with Anti-coagulants is mixed.Since part anti-coagulants can enter in plasma donor body with the also defeated of haemocyte, it may cause and offer slurry The uncomfortable reaction of member, another part anti-coagulants enter in collected raw blood plasma, reduce the protein content of raw blood plasma, and Influence the quality of terminal blood product.Blood plasma in blood of human body is different from the ratio of haemocyte, and difference between male is obvious, therefore, Under the premise of guaranteeing that Plasma Pheresis/Apheresis Plasma process blood coagulation does not occur, the fewer the use of anti-coagulants the better.
In addition, the degree of wear is different in long-term use for the moving component of machine in sampled plasma, lead to changes in flow rate It is different;For every suit consumptive material, characteristic value (pump is each to enclose the flow passed by) is influenced by many factors, comprising: pipe The internal diameter on road, wall thickness squeeze rebound velocity, the pressure etc. in pipeline.It, will if controlled according to theoretical value anti-coagulants Consume more actually unnecessary anti-coagulants.
Summary of the invention
Goal of the invention of the invention is: in order to solve in the prior art, when carrying out sampled plasma, anti-coagulants cannot be controlled accurately The problem of processed, the invention proposes a kind of anti-coagulants control systems and method for sampled plasma.
The technical scheme is that a kind of anti-coagulants control system for sampled plasma, comprising:
Anticoagulant pump, for driving anti-coagulants to flow in pipeline;
Blood pump, for driving blood to flow in pipeline;
Detection device, for detecting blood plasma and red cell proportion in blood;
First computing device, for calculating the mixing ratio of anti-coagulants and whole blood according to the ratio of blood plasma and red blood cell;
Control device, for when being obtained by the flow-rate ratio of anticoagulant pump and blood pump according to the mixing of anti-coagulants and whole blood Anticoagulant pump and blood pump rotating ratio control anticoagulant pump and blood pump rotation.
Further, further includes:
Flow measuring device, for calculating the flow-rate ratio for passing through anticoagulant pump and blood pump.
Further, further includes:
Counting device, for counting the turnning circle of anticoagulant pump and blood pump;
Second computing device for calculating the characteristic value of anticoagulant pump pipeline and the characteristic value of blood pump tubing, and calculates anti- The flow-rate ratio of setting agent pump and blood pump.
Further, further includes:
First metering device, for measuring plasma purity;
First empty spy, the second empty spy and third sky are visited, all interior with the presence or absence of air for detecting pipeline;
Described first empty visit is set on anti-coagulants pipeline, and the described second empty spy and the spy of third sky are sequentially arranged in blood conduit On.
Further, further includes:
Sensing device, the volume for measuring blood in Centrifuge Cup change;
4th empty visit is visited with the 5th sky, for detecting in pipeline with the presence or absence of air;
Described 4th empty visit is set on anti-coagulants pipeline, and the described 5th empty visit is set on blood conduit.
Further, further includes: the second metering device, for measuring anti-coagulants quality;Third metering device, for measuring Plasma purity.
The invention also provides a kind of anti-coagulants control methods for sampled plasma, comprising the following steps:
A, anti-coagulants and blood are respectively driven using anticoagulant pump and blood pump to flow in pipeline, and is examined using detection device Survey blood plasma and red cell proportion in blood;
B, the mixing ratio M of anti-coagulants and whole blood is calculated according to the ratio of blood plasma and red blood cell using the first computing device;
C, it is counted using counting device and is visited in detection pipeline without air to the second sky without sky in the first empty visit in detection pipeline Anticoagulant pump turnning circle during gas, and utilize the characteristic value T of the second computing device calculating anticoagulant pump pipelinek
D, it counts to visit in detection pipeline in third sky using counting device and counts blood plasma matter without air to the first metering device Amount reaches blood pump turnning circle during pulp distinguished value, and the characteristic value of blood pump tubing is calculated using the second computing device Tx
E, the anticoagulant pump pipeline feature value T according to obtained in step CkWith blood pump tubing characteristic value obtained in step D Tx, the rotating ratio of anticoagulant pump and blood pump is calculated using the second computing device, and anti-according to what is be calculated using control device The rotation of the rotating ratio of setting agent pump and blood pump control anticoagulant pump and blood pump.
Further, the rotating ratio of anticoagulant pump and blood pump is calculated in the step E using the second computing device, specifically Are as follows:
The revolving speed of anticoagulant pump is set as Vk, the revolving speed of blood pump is Vx, obtain the rotating ratio for calculating anticoagulant pump and blood pump Expression formula are as follows:
The invention also provides a kind of applied to the anti-of the anti-coagulants control method for being used for sampled plasma described in claim 7 The solidifying pre- punching method of agent, comprising the following steps:
S1, it is rotated using control device control blood pump and anticoagulant pump with same rotational speed, anti-coagulants is poured in pipeline;
S2, it is visited in detection pipeline without air to the second sky without sky using counting device statistics in the first empty visit in detection pipeline Anticoagulant pump turnning circle during gas.
The invention has the following advantages:
(1) it is detected by the blood plasma to each plasma donor with ratio of blood, personalized anti-coagulants is calculated Usage amount realizes the minimum using purpose of anti-coagulants, is beneficial to plasma donor health, also improves the blood plasma matter of acquisition Amount.
(2) it by carrying out real-time measurement to consumptive material characteristic value used in sampled plasma process, eliminates because of rotation section Part long-time service leads to the problem of abrasion and anti-coagulants caused by the form variations of appearance improves anti-coagulants dosage using increasing Control precision.
(3) it by being rushed in advance to anti-coagulants, direct measuring can be obtained through anticoagulant pump before carrying out adopting slurry Flow avoids and carries out excessive measuring and calculating operation during adopting slurry, ensure that the accurate dosage of anti-coagulants.
Detailed description of the invention
Fig. 1 is the anti-coagulants control system schematic diagram for sampled plasma of the invention.
Fig. 2 is the anti-coagulants control method flow diagram for sampled plasma of the invention.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to the accompanying drawings and embodiments, right The present invention is further elaborated.
As shown in Figure 1, being the anti-coagulants control system schematic diagram for sampled plasma of the invention.One kind is adopted for blood plasma The anti-coagulants control system of collection, comprising: anticoagulant pump, for driving anti-coagulants to flow in pipeline;Blood pump, for driving blood to exist Flowing in pipeline;Detection device, for detecting blood plasma and red cell proportion in blood;First computing device, for according to blood plasma The mixing ratio of anti-coagulants and whole blood is calculated with the ratio of red blood cell;Control device, for the mixing ratio according to anti-coagulants and whole blood And the rotating ratio of the anticoagulant pump and blood pump obtained by the flow-rate ratio of anticoagulant pump and blood pump controls anticoagulant pump and blood pump Rotation.
Anticoagulant pump and blood pump of the invention is all the common device during sampled plasma;Wherein, pacify on anticoagulant pump Equipped with anti-coagulants pipeline, anticoagulant pump is for driving the anti-coagulants in pipeline to flow;Similarly, blood tube is installed on blood pump Road, blood pump are used to drive the blood flow in pipeline.In the collection process of sampled plasma, anticoagulant pump and the same luck of blood pump Row promotes anti-coagulants and blood in pipeline to mix and flows into centrifuge;Sampled plasma it is also defeated during, only blood pump transport Row, anticoagulant pump are not run, and the red blood cell that blood pump drives obtain after centrifuge is centrifuged returns to human body.
Detection device of the invention is for detecting blood plasma and red cell proportion in blood.The realization of the function can be using logical The photodetector crossed in centrifuge detects the light transmittance of blood, according to the blood light transmittance that detection obtains obtains red blood cell ratio Hold, to obtain blood plasma and red cell proportion;The blood that can also be obtained after centrifuge is centrifuged using metering device measurement blood It starches quality, then by calculating it can be concluded that Quality of Erythrocyte, according to the density of blood plasma and red blood cell and then obtains blood plasma and red thin Born of the same parents' ratio;The red blood cell in pipeline can also be detected by the red blood cell detector on the plasma tube of Centrifuge Cup outlet, it is hot Cell detection device detection pipeline memory illustrates that Centrifuge Cup has been filled with red blood cell in red blood cell, is held according to piping volume and Centrifuge Cup Product calculates red blood cell volume, the plasma purity for recycling metering device measurement blood to obtain after centrifuge is centrifuged, by blood plasma matter Amount is converted into volume and blood plasma and red cell proportion in blood can be obtained.
First computing device of the invention is used to calculate the mixing of anti-coagulants and whole blood according to the ratio of blood plasma and red blood cell Than.The realization of the function obtains blood plasma after can performing mathematical calculations by the hematocrit value detected according to detection device With the ratio of red blood cell, perform mathematical calculations to obtain anti-coagulants and whole blood further according to the ratio of the blood plasma and red blood cell that are calculated Mixing ratio, anti-coagulants here refers to the capacity ratio that anti-coagulants is mixed with whole blood with the mixing ratio of whole blood.
Control device of the invention is used to when pass through according to the mixing of anti-coagulants and whole blood the stream of anticoagulant pump and blood pump Rotation of the amount than rotating ratio the control anticoagulant pump and blood pump of obtained anticoagulant pump and blood pump.The function can choose monolithic Machine, microprocessor (MCU) or central processing unit (CPU) etc. are realized;The rotating ratio of anticoagulant pump and blood pump can be by anti-coagulants Mixing with whole blood is when calculated by the flow-rate ratio of anticoagulant pump and blood pump;Pass through the flow-rate ratio of anticoagulant pump and blood pump Can be calculated by consumptive material specification, can also through the invention in the flow measuring method that is described below obtain.
Further, for the consumptive material difference of the modifying factor difference trade mark or lot number and caused by error, the invention also includes:
Flow measuring device, for calculating the flow-rate ratio for passing through anticoagulant pump and blood pump.It is driven according to anticoagulant pump anticoagulant The accurate control of anti-coagulants usage amount in blood may be implemented in the ratio of the flow of the flow and blood pump drives blood of agent, eliminates Because of existing for pipeline consumptive material various influence factors are influencing caused by anti-coagulants usage amount.
In order to calculate the flow-rate ratio by anticoagulant pump and blood pump, the present invention is illustrated with a kind of embodiment.
Flow measuring device of the invention includes: counting device, for counting the turnning circle of anticoagulant pump and blood pump;The Two computing devices for calculating the characteristic value of anticoagulant pump pipeline and the characteristic value of blood pump tubing, and calculate anticoagulant pump and blood The flow-rate ratio of pump;First metering device, for measuring plasma purity;First empty spy, the second empty spy and third sky are visited, all for examining It whether there is air in test tube road;First empty visit is set on anti-coagulants pipeline, and the described second empty spy and the spy of third sky are sequentially arranged in On blood conduit.
Counting device of the invention is used to count the operating circle number of anticoagulant pump and blood pump.The realization of the function can use Common logic circuit.
First metering device of the invention is for counting the plasma purity that blood obtains after centrifuge is centrifuged.The function Realization can use stent-type electronic scale;When in use, the plasma bags for being used to store blood plasma are placed on electronic scale bracket, electricity Son claims in real time to count plasma purity.
Of the invention first is empty to be visited, and the second sky is visited and third sky is visited and all whether there is air in pipeline for detecting, and first Sky, which is visited, to be set on anti-coagulants pipeline, and the described second empty spy and the spy of third sky are sequentially arranged on blood conduit.The realization of the function can To use common air detection device, its working principle is that using ultrasonic wave with different propagation speed in liquids and gases Degree is to judge whether be mixed with air in the blood in pipeline.
Second computing device of the invention is used to calculate the characteristic value of the characteristic value and blood pump tubing of anticoagulant pump pipeline, and Calculate the rotating ratio of anticoagulant pump and blood pump.The realization of the function can be counted according to counting device detects pipeline in the first empty visit Number is enclosed without anticoagulant pump operating in air event in interior no air to the second empty spy detection pipeline and passes through the anticoagulant of anticoagulant pump The characteristic value of agent calculation of capacity anticoagulant pump pipeline, the anti-coagulants capacity by anticoagulant pump here can be according to anti-coagulants pipe Road size and the first empty visit to the duct length between the second empty spy are calculated;Similarly, it can also be counted according to counting device Blood pump operates during reaching setting value without air to the first metering device statistics plasma purity in third sky visits detection pipeline It encloses number and calculates the characteristic value of blood pump tubing by the blood volume of blood pump, the blood volume by blood pump here can basis Centrifuge Cup capacity is visited to the calculation of capacity of blood conduit between plasma bags plus third sky and is obtained, and third sky is visited between plasma bags The capacity of blood conduit can be visited to the duct length between plasma bags according to blood conduit size and third sky and is calculated.This In characteristic value be defined as anticoagulant pump or blood pump operating after a week by the flow of anticoagulant pump or blood pump.Further according to anti-coagulants The characteristic value in pump line road and the characteristic value of blood pump tubing calculate the rotating ratio of anticoagulant pump and blood pump.
Preferably, in order to calculate the flow-rate ratio by anticoagulant pump and blood pump, another embodiment of the invention specifically:
Flow measuring device of the invention includes: counting device, for counting the turnning circle of anticoagulant pump and blood pump;The Two computing devices for calculating the characteristic value of anticoagulant pump pipeline and the characteristic value of blood pump tubing, and calculate anticoagulant pump and blood The flow-rate ratio of pump;Sensing device, the volume for measuring blood in Centrifuge Cup change;4th empty visit is visited with the 5th sky, for examining It whether there is air in test tube road;4th empty visit is set on anti-coagulants pipeline, and the described 5th empty visit is set on blood conduit.
Counting device of the invention is used to count the operating circle number of anticoagulant pump and blood pump.The realization of the function can use Common logic circuit.
Second computing device of the invention is used to calculate the characteristic value of the characteristic value and blood pump tubing of anticoagulant pump pipeline, and Calculate the rotating ratio of anticoagulant pump and blood pump.Realizing for the function can be according to the anticoagulant pump operating circle number that counting device counts And the characteristic value of the anti-coagulants calculation of capacity anticoagulant pump pipeline by anticoagulant pump, the anti-coagulants by anticoagulant pump here Capacity can be calculated according to empty visit to the duct length between the 5th empty spy of anti-coagulants line size and the 4th;Similarly, The characteristic value of blood pump tubing can be calculated according to the blood pump operating circle number that counting device counts and by the blood volume of blood pump, this In the blood volume by blood pump can perform mathematical calculations to obtain according to the volume of red blood cell and blood plasma.Here characteristic value Anticoagulant pump or blood pump operating are defined as after a week by anticoagulant pump or the flow of blood pump.Further according to the spy of anticoagulant pump pipeline Value indicative and the characteristic value of blood pump tubing calculate the rotating ratio of anticoagulant pump and blood pump.
Sensing device of the invention is used to measure the volume variation of blood in Centrifuge Cup.The realization of the function can by from Photodetector in scheming detects the light transmittance of blood, further according to the boundary of blood determination of light transmittance red blood cell and blood plasma Line can respectively obtain the volume of red blood cell and blood plasma by the line of demarcation.
The empty spy of of the invention the 4th and the 5th empty spy all whether there is air for detecting in pipeline, the 4th empty spy is set to anti- On solidifying agent pipeline, the described 5th empty visit is set on blood conduit.The realization of the function can use common air detection device, Its working principle is that having different spread speeds to judge in the blood in pipeline in liquids and gases using ultrasonic wave Whether air is mixed with.
Preferably, in order to calculate the flow-rate ratio by anticoagulant pump and blood pump, the third embodiment of the invention specifically:
Flow measuring device of the invention includes: counting device, for counting the turnning circle of anticoagulant pump and blood pump;The Two computing devices for calculating the characteristic value of anticoagulant pump pipeline and the characteristic value of blood pump tubing, and calculate anticoagulant pump and blood The flow-rate ratio of pump;Second metering device, for measuring anti-coagulants quality;Third metering device, for measuring plasma purity.
Counting device of the invention is used to count the operating circle number of anticoagulant pump and blood pump.The realization of the function can use Common logic circuit.
Second metering device of the invention is used to measure the quality of anti-coagulants in anti-coagulants bag.The realization of the function can adopt With stent-type electronic scale;When in use, the anti-coagulants bag for being stored with anti-coagulants is placed on electronic scale bracket, electronic scale is real-time Anti-coagulants quality is counted.
Third metering device of the invention is for measuring the plasma purity that blood obtains after centrifuge is centrifuged.The function Realization can use stent-type electronic scale;When in use, the plasma bags for being used to store blood plasma are placed on electronic scale bracket, electricity Son claims in real time to count plasma purity.
Second computing device of the invention is used to calculate the characteristic value of the characteristic value and blood pump tubing of anticoagulant pump pipeline, and Calculate the rotating ratio of anticoagulant pump and blood pump.The realization of the function can be counted according to counting device detects pipeline in the first empty visit Number is enclosed without anticoagulant pump operating in air event in interior no air to the second empty spy detection pipeline and passes through the anticoagulant of anticoagulant pump The characteristic value of agent calculation of capacity anticoagulant pump pipeline, the anti-coagulants capacity by anticoagulant pump here can be according to the second metering The anti-coagulants qualitative data of device measurement is calculated;Similarly, it can also be counted to visit in third sky according to counting device and detected Reach blood pump operating circle number during setting value without air to the first metering device statistics plasma purity in pipeline and passes through blood pump Blood volume calculate the characteristic value of blood pump tubing, the blood volume by blood pump here can survey according to third metering device Fixed plasma purity is calculated.Here characteristic value be defined as anticoagulant pump or blood pump operating after a week by anticoagulant pump or The flow of blood pump.The characteristic value of characteristic value and blood pump tubing further according to anticoagulant pump pipeline calculates turn of anticoagulant pump and blood pump Speed ratio.
The present invention is further appreciated that for the ease of those skilled in the art, and the targeted use of the present invention is described below In the solidifying agent control method of the anti-coagulants control system of sampled plasma.
As shown in Fig. 2, being the anti-coagulants control method flow diagram for sampled plasma of the invention.One kind being used for blood Starch the anti-coagulants control method of acquisition, comprising the following steps:
A, anti-coagulants and blood are respectively driven using anticoagulant pump and blood pump to flow in pipeline, and is examined using detection device Survey blood plasma and red cell proportion in blood;
B, the mixing ratio M of anti-coagulants and whole blood is calculated according to the ratio of blood plasma and red blood cell using the first computing device;
C, it is counted using counting device and is visited in detection pipeline without air to the second sky without sky in the first empty visit in detection pipeline Anticoagulant pump turnning circle during gas, and utilize the characteristic value T of the second computing device calculating anticoagulant pump pipelinek
D, it counts to visit in detection pipeline in third sky using counting device and counts blood plasma matter without air to the first metering device Amount reaches blood pump turnning circle during pulp distinguished value, and the characteristic value of blood pump tubing is calculated using the second computing device Tx
E, the anticoagulant pump pipeline feature value T according to obtained in step CkWith blood pump tubing characteristic value obtained in step D Tx, the rotating ratio of anticoagulant pump and blood pump is calculated using the second computing device, and anti-according to what is be calculated using control device The rotation of the rotating ratio of setting agent pump and blood pump control anticoagulant pump and blood pump.
In step, anticoagulant pump and blood pump are run simultaneously, respectively drive anti-coagulants and blood using anticoagulant pump and blood pump Liquid flows in pipeline, and promotes anti-coagulants and blood in pipeline to mix and flow into centrifuge.Pass through the photoelectricity in centrifuge again Detector detects the light transmittance of blood, obtains hematocrit value according to the blood light transmittance that detection obtains, to obtain blood plasma With red cell proportion;Preferably, the plasma purity that can also be obtained after centrifuge is centrifuged using metering device measurement blood, then By calculating it can be concluded that Quality of Erythrocyte, further according to the density of blood plasma and red blood cell and then obtains the ratio of blood plasma and red blood cell Example;Preferably, the red blood cell in pipeline can also be detected by the red blood cell detector on the plasma tube of Centrifuge Cup outlet, when Red blood cell detector detection pipeline memory illustrates that Centrifuge Cup has been filled with red blood cell in red blood cell, according to piping volume and Centrifuge Cup Volume calculations red blood cell volume, the plasma purity for recycling metering device measurement blood to obtain after centrifuge is centrifuged, by blood plasma Blood plasma and red cell proportion in blood can be obtained at volume in mass conversion.
In stepb, the blood plasma and red cell proportion detected using the first computing device according to detection device is carried out The mixing ratio M of anti-coagulants and whole blood is obtained after mathematical operation.
In step C, anticoagulant pump driving anti-coagulants flows in pipeline, detects in pipeline in anti-coagulants in the first empty visit It is detected using counting device statistics in the first empty visit in anti-coagulants without in air event in no air to the second empty spy detection pipeline It is detected in pipeline without air to the second empty visit without anticoagulant pump turnning circle in air event in pipeline;Second is recycled to calculate dress It sets according to the anticoagulant pump operating circle number of counting device statistics and by the anti-coagulants calculation of capacity anti-coagulants pump line of anticoagulant pump The characteristic value in road operates circle number divided by anticoagulant pump using the anti-coagulants capacity by anticoagulant pump and obtains anticoagulant pump pipeline Characteristic value Tk
In step D, it is similar to step C, blood pump drives blood flows in pipeline, visits blood in detection pipeline in third sky During reaching setting value to the first metering device statistics plasma purity without air in liquid, using counting device statistics in third sky It visits in detection pipeline and reaches blood pump turning collar during pulp distinguished value without air to the first metering device statistics plasma purity Number;The blood pump operating for recycling the second computing device to be counted according to counting device encloses number and calculates blood by the blood volume of blood pump The characteristic value in pump line road is pumped, i.e., operates circle number divided by blood pump using the blood volume by blood pump and obtains the characteristic value of blood pump tubing Tx
In step E, using the second computing device according to the characteristic value T of anticoagulant pump pipelinekWith the feature of blood pump tubing Value TxCalculate the rotating ratio of anticoagulant pump and blood pump.Here the rotating ratio obtained eliminates because of anti-coagulants caused by consumptive material loss The problem of using increasing.
The present invention is further appreciated that for the ease of those skilled in the art, is come below with specific embodiment to this hair The algorithm of the bright middle rotating ratio that anticoagulant pump and blood pump are calculated using the second computing device is illustrated.
The revolving speed of anticoagulant pump is set as Vk, the revolving speed of blood pump is Vx, obtain the rotating ratio for calculating anticoagulant pump and blood pump Expression formula are as follows:
The invention also provides a kind of anti-coagulants applied to the anti-coagulants control method for sampled plasma of the invention Pre- punching method, which comprises the following steps:
S1, it is rotated using control device control blood pump and anticoagulant pump with same rotational speed, anti-coagulants is poured in pipeline;
S2, it is visited in detection pipeline without air to the second sky without sky using counting device statistics in the first empty visit in detection pipeline Anticoagulant pump turnning circle during gas.
The pre- punching method of anti-coagulants of anti-coagulants control method for sampled plasma of the invention is used to adopt in progress blood plasma Before collection, accurately calculating to the anticoagulant agent flux by anticoagulant pump is realized.
The present invention is further appreciated that for the ease of those skilled in the art, is come below with specific embodiment to this hair The pre- punching method of anti-coagulants of anti-coagulants control method in bright for sampled plasma is described further.
Since the pre- punching method of anti-coagulants of the invention is for before carrying out sampled plasma, at this time blood collection needles pipeline and Saline needle pipeline is all in closed state;It is carried out before rushing in advance, is needed anti-coagulants using the pre- punching method of anti-coagulants of the invention Syringe needle is inserted into the outlet of anti-coagulants bag, then starts anti-coagulants and rushes in advance.
Blood pump and anticoagulant pump are controlled first with control device to be rotated clockwise with same rotational speed, and anti-coagulants is rushed Enter in pipeline;When in the first empty spy detection pipeline without air, start the turnning circle for counting anticoagulant pump using counting device; When in the second empty spy detection pipeline without air, terminate the turnning circle for counting anticoagulant pump using counting device.By anticoagulant The anti-coagulants capacity of agent pump can be calculated according to empty visit to the duct length between the second empty spy of anti-coagulants line size and first It arrives, anticoagulant pump operating circle number further according to counting device statistics and what is obtained can be counted by the anti-coagulants capacity of anticoagulant pump Calculate the exact flow rate of anticoagulant pump.
Those of ordinary skill in the art will understand that the embodiments described herein, which is to help reader, understands this hair Bright principle, it should be understood that protection scope of the present invention is not limited to such specific embodiments and embodiments.This field Those of ordinary skill disclosed the technical disclosures can make according to the present invention and various not depart from the other each of essence of the invention The specific variations and combinations of kind, these variations and combinations are still within the scope of the present invention.

Claims (1)

1. a kind of pre- punching method of anti-coagulants for sampled plasma, which comprises the following steps:
S1, it is rotated using control device control blood pump and anticoagulant pump with same rotational speed, anti-coagulants is poured in pipeline;
S2, it is visited in detection pipeline without air to the second sky without air mistake using counting device statistics in the first empty visit in detection pipeline Anticoagulant pump turnning circle in journey;
S3, it is visited in detection pipeline without air to the second sky without sky using the measurement of the second gravity measure device in the first empty visit in detection pipeline During gas in anti-coagulants bag anti-coagulants mass change data;
S4, the anticoagulant pump turnning circle and the second gravity measure device counted using the second computing device according to counting device are measured Anti-coagulants mass change data calculate the characteristic value of anticoagulant pump pipeline in anti-coagulants bag.
CN201610257181.5A 2015-04-24 2015-04-24 The pre- punching method of anti-coagulants for sampled plasma Active CN105854105B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610257181.5A CN105854105B (en) 2015-04-24 2015-04-24 The pre- punching method of anti-coagulants for sampled plasma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510198723.1A CN104800905B (en) 2015-01-16 2015-04-24 Anticoagulant control system for sampled plasma
CN201610257181.5A CN105854105B (en) 2015-04-24 2015-04-24 The pre- punching method of anti-coagulants for sampled plasma

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201510198723.1A Division CN104800905B (en) 2015-01-16 2015-04-24 Anticoagulant control system for sampled plasma

Publications (2)

Publication Number Publication Date
CN105854105A CN105854105A (en) 2016-08-17
CN105854105B true CN105854105B (en) 2019-08-06

Family

ID=56681870

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610257181.5A Active CN105854105B (en) 2015-04-24 2015-04-24 The pre- punching method of anti-coagulants for sampled plasma
CN201510198723.1A Active CN104800905B (en) 2015-01-16 2015-04-24 Anticoagulant control system for sampled plasma

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510198723.1A Active CN104800905B (en) 2015-01-16 2015-04-24 Anticoagulant control system for sampled plasma

Country Status (1)

Country Link
CN (2) CN105854105B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11386993B2 (en) 2011-05-18 2022-07-12 Fenwal, Inc. Plasma collection with remote programming
CN107789693B (en) * 2017-10-31 2019-07-23 四川南格尔生物科技有限公司 A kind of sampled plasma system optimizing anti-coagulants dosage
US11412967B2 (en) 2018-05-21 2022-08-16 Fenwal, Inc. Systems and methods for plasma collection
EP3954407B1 (en) 2018-05-21 2023-07-12 Fenwal, Inc. Systems and methods for optimization of plasma collection volumes
CN110215217A (en) * 2019-06-05 2019-09-10 四川南格尔生物科技有限公司 A kind of sampled plasma system and method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN201434867Y (en) * 2008-11-13 2010-03-31 镇江奥迪康医疗仪器有限责任公司 Peristaltic pump calibrating device of electrolyte analyzer
CN201731923U (en) * 2010-04-17 2011-02-02 普耐美流体系统有限公司 Flow calibrator
CN103464075A (en) * 2013-09-10 2013-12-25 张家港保税区万盛机械工业有限公司 Polyester experiment device
CN103561798A (en) * 2011-05-27 2014-02-05 基立福有限公司 Priming anticoagulant line for blood extraction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1157233C (en) * 1998-11-20 2004-07-14 成都迪康血液科技有限公司 Plasma separator of hollow fibre membrane and its blood taking and separating method
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US8372025B2 (en) * 2005-09-22 2013-02-12 Baxter International Inc. Automation and optimization of CRRT treatment using regional citrate anticoagulation
US8628489B2 (en) * 2008-04-14 2014-01-14 Haemonetics Corporation Three-line apheresis system and method
CN101653630B (en) * 2009-09-16 2013-06-05 北京鑫禾丰医疗技术有限公司 Infusion pump calibration device
US9603989B2 (en) * 2010-08-24 2017-03-28 Fenwal, Inc. Methods for anticoagulating blood
DE102011010406A1 (en) * 2011-02-04 2012-08-09 Fresenius Medical Care Deutschland Gmbh A method of controlling a blood treatment device, control device, delivery device and blood treatment device
CN103055365B (en) * 2013-01-22 2016-03-02 欧阳锡林 The blood processing system of autologous storage blood
JP5607197B2 (en) * 2013-03-11 2014-10-15 東洋ゴム工業株式会社 Gear pump life prediction method and rubber extrusion device
CN204395097U (en) * 2015-01-16 2015-06-17 成都市佳颖医用制品有限公司 For the anticoagulant control system of sampled plasma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN201434867Y (en) * 2008-11-13 2010-03-31 镇江奥迪康医疗仪器有限责任公司 Peristaltic pump calibrating device of electrolyte analyzer
CN201731923U (en) * 2010-04-17 2011-02-02 普耐美流体系统有限公司 Flow calibrator
CN103561798A (en) * 2011-05-27 2014-02-05 基立福有限公司 Priming anticoagulant line for blood extraction
CN103464075A (en) * 2013-09-10 2013-12-25 张家港保税区万盛机械工业有限公司 Polyester experiment device

Also Published As

Publication number Publication date
CN104800905A (en) 2015-07-29
CN105854105A (en) 2016-08-17
CN104800905B (en) 2016-12-28

Similar Documents

Publication Publication Date Title
CN105854105B (en) The pre- punching method of anti-coagulants for sampled plasma
CN103747821B (en) For determining the method and device of at least one parameter of extracorporeal blood circuit
ES2348407T3 (en) APPLIANCE TO CONTROL THE BLOOD FLOW IN AN EXTRACORPORE CIRCUIT.
CN1946441B (en) Blood treatment equipment, method for controlling infusion
JP2009240825A (en) Method and device for detecting leakage in fluid system of blood treatment apparatus
CN104321088B (en) For determining the device of the parameter of the progress of instruction extracorporeal blood treatment
CN107952140A (en) A kind of disengaging liquid balance system for hydration treatment
CN106535956B (en) Duration blood purification device
CN206740465U (en) A kind of flue gas constant-speed sampling device
CN204261114U (en) The method and apparatus of self-filtering is judged in vitro during blood treatment
CN103033482A (en) Full-automatic determining instrument of red blood cell osmotic fragility
CN104502231B (en) Double capillary viscometer for high temperature and high pressure and test method thereof
CN204395097U (en) For the anticoagulant control system of sampled plasma
CN104970767B (en) Device and method for determining the distribution volume of a dialysis patient
CN202793472U (en) Single phase liquid microscale flowmeter
CN108663499A (en) A kind of assembled tube type high pressure seepage flow leaching test device
CN108776091A (en) Silicious dust concentration detection method in a kind of Work places
CN106235401A (en) For manufacturing the machine of the filtering rod of the tobacco industry, method and coating unit
CN105431713A (en) Viscosity-dependent flow meter for fuel dispensing environments
US6440311B1 (en) System and method for monitoring a dosage pump in a dialysis machine
CN204514403U (en) A kind of differential pressure mass flowmeter for vortex street
CN107084926B (en) Liquid clarity detection method, system and device
CN208383644U (en) Solid Releasing Fresh-keeping Agent sustained release performance evaluating apparatus
RU2371701C1 (en) Method for detection of contaminants content in liquid that flows in pipeline
CN207798137U (en) The device of measurement accuracy is improved in a kind of ground During Oil Testing Process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant